drugset / Trial / NCT03397771
DBPC Trial to Evaluate the Safety, Tolerability and Efficacy of Oral Litoxetine in Subjects With Urinary Incontinence
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will explore the safety, tolerability and efficacy of litoxetine in men and women who suffer from urinary incontinence
Timeline
- Start
- 2018-04-03
- Primary completion
- 2019-05-30
- Completion
- 2019-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Litoxetine | Small molecule | 30 mg | Oral |
Indications
No indication recorded.